Skip to content

Clinical trials

Completed Adenocarcinoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Japan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20131
20161
20171
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Sumitomo Pharma America, Inc.2
Australasian Gastro-Intestinal Trials Group1
Boehringer Ingelheim1
Daiichi Sankyo Co., Ltd.1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma8
Neoplasms3
Digestive System Diseases2
Digestive System Neoplasms2
Neoplasms by Site2
Neoplasms, Glandular and Epithelial2
Pancreatic Neoplasms2
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Pancreatic Ductal1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.